1.
Vaishali Sanchorawala, Jaymin M. Patel, J. Mark Sloan, Anthony C. Shelton, Jerome B. Zeldis, David C. Seldin. Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial. haematol [Internet]. 2013May1 [cited 2022Oct.1];98(5):789-92. Available from: https://haematologica.org/article/view/6670